{"id":682,"date":"2023-12-28T11:15:21","date_gmt":"2023-12-28T02:15:21","guid":{"rendered":"https:\/\/www.sonire-therapeutics.com\/?p=682"},"modified":"2025-11-25T19:35:05","modified_gmt":"2025-11-25T10:35:05","slug":"nhk-wolrd_broadcast_202401_en","status":"publish","type":"post","link":"https:\/\/www.sonire-therapeutics.com\/en\/nhk-wolrd_broadcast_202401_en\/","title":{"rendered":"HIFU treatment for pancreatic cancer will be broadcast on NHK WOLRD"},"content":{"rendered":"\n<p>SONIRE Therapeutics Inc. (Headquarters: Shinjuku-ku, Tokyo; President and CEO, Co-Founder: Tohru Satoh; hereinafter referred to as &#8220;SONIRE&#8221;), announces that NHK WOLRD&#8217;s &#8220;Medical Frontiers&#8221; will focus on HIFU therapy for pancreatic cancer, and the next-generation HIFU (High-Intensity Focused Ultrasound) therapy device, which has been developed by SONIRE, will be introduced in the program.<\/p>\n\n\n\n<p>The program outline is as follows.<br>Title : Destroying Pancreatic Cancer With Ultrasound<br>Program Title : NHK World &#8220;Medical Frontiers&#8221;<br>Broadcast date and time :<br>January 8 (Mon) 23:30\uff08JST\uff09<br>January 9 (Tue) 05:30\uff08JST\uff09 &nbsp;[Rebroadcast]<br>January 9 (Tue) 12:30\uff08JST\uff09 &nbsp;[Rebroadcast]<br>January 9 (Tue) 18:30\uff08JST\uff09&nbsp; [Rebroadcast]<br>January 27 (Sat) 04:30\uff08JST\uff09 [NHK BS1]<br>Live streaming broadcast :<br>You can watch the live streaming from the official website.<br><a rel=\"noreferrer noopener\" href=\"https:\/\/www.nhk.or.jp\/nhkworld\/en\/live\/\" target=\"_blank\">https:\/\/www.nhk.or.jp\/nhkworld\/en\/live\/<\/a><\/p>\n\n\n\n<p>On-demand Broadcasting :<br>After the rebroadcast ends, the program can be viewed for one year via on-demand broadcasting.<br><a rel=\"noreferrer noopener\" href=\"https:\/\/www.nhk.or.jp\/nhkworld\/en\/tv\/medicalfrontiers\/\" target=\"_blank\">https:\/\/www.nhk.or.jp\/nhkworld\/en\/tv\/medicalfrontiers\/<\/a><\/p>\n\n\n\n<p>For details, please refer to the following URL.<br><a rel=\"noreferrer noopener\" href=\"https:\/\/www.nhk.or.jp\/nhkworld\/en\/tv\/medicalfrontiers\/20240108\/2050151\/\" target=\"_blank\">https:\/\/www.nhk.or.jp\/nhkworld\/en\/tv\/medicalfrontiers\/20240108\/2050151\/<\/a><\/p>\n\n\n\n<p>SONIRE will continue to promote our business in order to realize the wish we put in our company name at the time of our foundation: &#8221; Sonics\uff08Ultrasound\uff09 Brings New Future to Cancer Patients and Families.&#8221;.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.sonire-therapeutics.com\/wp-content\/uploads\/2023\/12\/SONIRE_News-Release_NHK-Wolrd-Broadcast-231228_EN_v2.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Download PDF file<\/a><\/div>\n<\/div>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SONIRE Therapeutics Inc. (Headquarters: Shinjuku-ku, Tokyo; President and CEO, Co-Founder: Tohru Satoh; hereinafter referred to as &#8220;SONIRE&#8221;), announces that NHK WOLRD&#8217;s &#8220;Medical Frontiers&#8221; will focus on HIFU therapy for pancreatic cancer, and the next-generation HIFU (High-Intensity Focused Ultrasound) therapy device, which has been developed by SONIRE, will be introduced in the program. The program outline [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_locale":"en_US","_original_post":"https:\/\/www.sonire-therapeutics.com\/?p=674","footnotes":""},"categories":[11],"tags":[],"class_list":["post-682","post","type-post","status-publish","format-standard","hentry","category-publication","en-US"],"_links":{"self":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/comments?post=682"}],"version-history":[{"count":7,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/682\/revisions"}],"predecessor-version":[{"id":690,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/posts\/682\/revisions\/690"}],"wp:attachment":[{"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/media?parent=682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/categories?post=682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sonire-therapeutics.com\/wp-json\/wp\/v2\/tags?post=682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}